HISTORY OF PRESENT ILLNESS:  Patient is a 78-year-old gentlemen with a known history of coronary artery disease, status post coronary artery bypass [**Year (4 digits) **] in [**2112**] (grafts are left internal mammary artery to left anterior descending, saphenous vein [**Year (4 digits) **] to right coronary artery and saphenous vein [**Year (4 digits) **] to OM).
Coronary artery bypass [**Hospital6 **] in [**2112**] with saphenous vein [**Year (4 digits) **] to left anterior descending, saphenous vein [**Year (4 digits) **] to OM and saphenous vein [**Year (4 digits) **] to right coronary artery.
Left carotid endarterectomy in [**2130**].
MEDICATIONS ON ADMISSION:  Norvasc 10 mg po q.d., Atenolol 100 mg po q.d., Lasix 20 mg po q.d., trental 400 mg po b.i.d., Imdur 60 mg po b.i.d., Lipitor 20 mg po q.d., aspirin 325 mg po q.d., nitropatch .4 mg po q.d., Vitamins po q.d., garlic po q.d.
FAMILY HISTORY:  Significant for a 39-year-old daughter status post myocardial infarction times two.
The patient tolerated this procedure well and was then evaluated by Cardiothoracic Surgery Team.
On hospital day two, the patient was taken to the Operating Room under Dr. [**Last Name (STitle) **] and the Cardiothoracic Team where he underwent a redo coronary artery bypass [**Last Name (STitle) **] times three with left internal mammary artery to left anterior descending distal, saphenous vein [**Last Name (STitle) **] to left anterior descending proximal, saphenous vein [**Last Name (STitle) **] to OM.
He tolerated this procedure well and was transferred to the Cardiothoracic Surgery Unit in stable condition.
Patient failed ventilatory wean times two.
Patient was placed on nebulizer treatments, inhaler treatments and was evaluated by the Pulmonary Medicine Team.
They recommended optimizing fluid balance and continuing with nebulizers until patient stabilized.
Patient continued to undergo weaning from the ventilatory support and was extubated successfully on postoperative day number one.
Post extubation, patient developed laryngeal edema and was given racemic epinephrine by the respiratory therapist and the edema resolved.
Patient's respiratory status continued to slowly improve with aggressive pulmonary toilet and nebulizer treatments with albuterol and Atrovent and gentle diuresis.
Patient's chest tubes were discontinued without incident.
Patient remained hemodynamically stable with occasional premature ventricular contractions seen on the monitor.
Of note, prior to OR, patient underwent cystoscopy guided Foley catheter insertion secondary to stricture in the urethra.
Patient's Foley was discontinued on postoperative day number five and has been able to void.
Patient was started on intravenous Kefzol.
After no improvement over the ensuing day, the patient was switched to intravenous vancomycin.
Cellulitis has resolved after five days of vancomycin intravenously.
Patient remained afebrile during this time and patient will be discharged with a po clindamycin for an extended period of time for the wound cellulitis.
Otherwise, patient remained stable and is tolerating a cardiac diet and has been restarted on all medications po and is now stable and ready for discharge with VNA Service.
Coronary artery disease, status post redo coronary artery bypass [**Last Name (STitle) **] times three.
Norvasc 10 mg po q.d.
Lipitor 20 mg po q.d.
Enteric coated aspirin 325 mg po q.d.
Lopressor 75 mg po b.i.d.
Colace 100 mg po b.i.d.
Plavix 75 mg po q.d.
Imdur 60 mg po q.d.
Lasix 40 mg po b.i.d.
Trental 400 mg po b.i.d.
Percocet [**5-/3382**]-2 po q.
Clindamycin 300 mg po q.i.d.
